The FDA has approved Pfizer's eplerenone (Inspra) for the treatment of congestive heart failure (CHF) in patients who have sustained a myocardial infarction.
The objective of this monograph is to provide an overview of the scope of allergic disorders, and review the current understanding of the mechanism of the allergic response. Due to the extensive nature of the topic, we will limit our discussion to systemic reactions eliciting an IgE-mediated response. Further, the intimate relationship between organs involved will be reviewed, particularly the relationship between allergic rhinitis and asthma. Part I includes the current evaluation, including historical features, exposures, physical exam findings, and ancillary diagnostic options will be reviewed.
The FDA has approved Pfizer's eplerenone (Inspra) for the treatment of congestive heart failure (CHF) in patients who have sustained a myocardial infarction.
Some of the key aspects of the Joint Commission on Accreditation of Healthcare Organizations 2005 infection control standards are summarized here:
The Centers for Disease Control and Prevention (CDC) provides the following answers to some of the most frequently asked questions about community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).
Infection control is one of the key areas cited in a recent national report warning that nursing staffing problems pose a grave threat to patient safety.
The Joint Commission on Accreditation of Healthcare Organizations has issued new infection control standards for 2005, emphasizing at a conference in Chicago that hospital executives not ICPs are going to have to take ultimate responsibility for enacting them.
